For the first quarter of the fiscal year ending March 2027, consolidated net sales were JPY 8.27 billion, up 15.8% YoY. Operating profit was JPY 528 million, up 79.2% YoY; quarterly net income attributable to owners of the parent was JPY 370 million, up significantly. The full-year earnings guidance remains unchanged from the prior disclosure. The dividend forecast remains at 36 yen per share for the year (annual plan).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9780","jir_company_name":"Harima Biostem Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-08-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/9780-20260812-01.pdf","jir_short_summary":"For the first quarter of the fiscal year ending March 2027, consolidated net sales were JPY 8.27 billion, up 15.8% YoY. Operating profit was JPY 528 million, up 79.2% YoY; quarterly net income attributable to owners of the parent was JPY 370 million, up significantly. The full-year earnings guidance remains unchanged from the prior disclosure. The dividend forecast remains at 36 yen per share for the year (annual plan).","jir_summary":"### Overview of performance\nThis quarter's net sales increased significantly year over year, driven by the full-scale operation of new properties, contract renewals, increased incidental work, and growth of group companies. On the profit front, cost of sales and selling, general and administrative expenses were restrained, resulting in substantial increases in operating income, ordinary income, and net profit. In line with the medium-term plan, investment in human resources and DX\/AI investments was advanced to strengthen organizational capability and value addition.\n\n### Outlook and capital elements\nFull-year earnings guidance remains unchanged since the previous disclosure. Even considering higher personnel costs and education\/training expenses from the second quarter onward, the outlook remains in line with the initial plan. The financial position shows increases in cash and deposits and long-term borrowings, while liquidity, net assets, and overall positions remain sound.","jir_financial_highlights":"Revenue: 82,07,000,000\u5186 (YoY increase of 1,122,000,000 yen (+15.8%))\nOperating profit: 528,464,000\u5186 (YoY increase of 236,000,000 yen (+81.1%))\nOrdinary income: 558,214,000\u5186 (YoY increase of 246,000,000 yen (+79.2%))\nNet income attributable to owners of the parent: 370,396,000\u5186 (YoY increase of 145,000,000 yen (+64.6%))\nTotal assets: 174,983,000,000\u5186 (Increased by 2,600,000,000 yen from end of previous period)\nShareholders' equity ratio: 58.6% (Up 0.8 percentage points from end of previous period)","jir_category":"","jir_hashtags":"#HarimaBiostem, #FinancialResults, #MediumTermPlan","jir_key_figures":"Revenue: 82,07,000\u5343\u5186 (YoY +15.8%)\nOperating profit: 528,464\u5343\u5186 (YoY +81.1%)\nNet income attributable to owners of the parent: 370,396\u5343\u5186 (YoY +64.6%)","jir_meta_title":"Harima Biostem \uff5c First Quarter of Fiscal Year Ending March 2027 Financial Results | Revenue Exceeding 8.2 Billion Yen, YoY +15.8%","jir_meta_description":"Key points of Harima Biostem's first quarter results for the fiscal year ending March 2027. Revenue was 8.27 billion yen, operating profit 528 million yen, net income 370 million yen, with significant increases. Full-year guidance unchanged.","jir_og_title":"Harima Biostem | Earnings Flash: Q1 Major KPIs","jir_og_description":"Harima Biostem's Q1 results for the fiscal year ending March 2027 show revenue in the 8x billion yen range, operating profit above 500 million yen, and net income above 300 million yen, with full-year forecast unchanged.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":0,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-101770","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n